Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Preston Klassen currently holds 528,000 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Preston Klassen has been a net seller of OREX stock. They have purchased $74.8K and sold $1.7M worth of shares.
Preston Klassen's most recent insider trade was on May 20, 2024, when they sold 528,000 shares at $0.00 per share.
Preston Klassen serves as Executive at Orexigen Therapeutics, Inc. (OREX). They have executed 25 insider transactions totaling $1.8M over their tenure at the company.
Preston Klassen holds the position of Executive at Orexigen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Preston Klassen has shown a selling trading pattern, with $74.8K in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Preston Klassen was on Jan 7, 2019, when they sold $650.2K worth of ARNA shares. This transaction involved 15,600 shares at $41.68 per share.
Preston Klassen currently owns 528,000 shares of Orexigen Therapeutics, Inc. (OREX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Preston Klassen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Preston Klassen has 25 Form 4 filings on record as an insider at Orexigen Therapeutics, Inc..
Set alerts for Preston Klassen and 40,000+ other insiders.